p-value | HR | 95% CI | |
Univariate analysis | |||
Age: for each year | 0.74 | 1.00 | 0.96–1.04 |
Sex: male versus female | 0.65 | 0.84 | 0.41–1.75 |
Pack–years: for each pack–year | 0.001 | 1.02 | 1.01–1.03 |
BMI: for each kg·m−2 | 0.03 | 0.92 | 0.85–0.99 |
Emphysema: yes versus no | 0.001 | 4.11 | 2.26–7.47 |
COPD: yes versus no | 0.001 | 4.23 | 2.34–7.63 |
Telomere length quartiles | |||
Q1: reference (shortest telomere length) | 0.001 | ||
Q2 versus Q1 | 0.85 | 0.90 | 0.29–2.79 |
Q3 versus Q1 | 0.21 | 1.86 | 0.69–4.98 |
Q4 versus Q1 | 0.001 | 4.38 | 1.79–10.7 |
Multivariate analysis | |||
Pack–years: for each pack–year | 0.015 | 1.01 | 1.00–1.02 |
Emphysema: yes versus no | 0.002 | 2.68 | 1.42–5.05 |
COPD: yes versus no | 0.001 | 2.96 | 1.60–5.49 |
Telomere length quartiles | |||
Q1: reference (shortest telomere length) | 0.001 | ||
Q2 versus Q1 | 0.88 | 0.92 | 0.29–2.86 |
Q3 versus Q1 | 0.17 | 1.99 | 0.74–5.36 |
Q4 versus Q1 | 0.003 | 3.97 | 1.62–9.72 |
HR: hazard ratio; BMI: body mass index; COPD: Chronic obstructive pulmonary disease; Q: quartile.